Linaclotide in the treatment of patients with irritable bowel syndrome and constipation: analysis of an opportunity
Linaclotide is a secretagogue that provides a combined effect on visceral pain. The European Medicines Agency has authorized its indication for the symptomatic treatment of moderate to severe irritable bowel syndrome with constipation in adults. The purpose of this review is to discuss the clinical...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Aran Ediciones
2013-06-01
|
| Series: | Revista Espanola de Enfermedades Digestivas |
| Subjects: | |
| Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082013000600006&lng=en&tlng=en |